129 related articles for article (PubMed ID: 8814071)
1. Epitope analysis of the major reactive region of the 100-kd protein of PM-Scl autoantigen.
Ge Q; Wu Y; James JA; Targoff IN
Arthritis Rheum; 1996 Sep; 39(9):1588-95. PubMed ID: 8814071
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the specificity of anti-PM-Scl autoantibodies.
Ge Q; Wu Y; Trieu EP; Targoff IN
Arthritis Rheum; 1994 Oct; 37(10):1445-52. PubMed ID: 7945469
[TBL] [Abstract][Full Text] [Related]
3. Mapping of epitopes recognized by PM/Scl autoantibodies with gene-fragment phage display libraries.
Blüthner M; Bautz EK; Bautz FA
J Immunol Methods; 1996 Nov; 198(2):187-98. PubMed ID: 8946014
[TBL] [Abstract][Full Text] [Related]
4. Cloning of a complementary DNA coding for the 100-kD antigenic protein of the PM-Scl autoantigen.
Ge Q; Frank MB; O'Brien C; Targoff IN
J Clin Invest; 1992 Aug; 90(2):559-70. PubMed ID: 1644924
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen.
Mahler M; Raijmakers R; Dähnrich C; Blüthner M; Fritzler MJ
Arthritis Res Ther; 2005; 7(3):R704-13. PubMed ID: 15899056
[TBL] [Abstract][Full Text] [Related]
6. PM-Scl-75 is the main autoantigen in patients with the polymyositis/scleroderma overlap syndrome.
Raijmakers R; Renz M; Wiemann C; Egberts WV; Seelig HP; van Venrooij WJ; Pruijn GJ
Arthritis Rheum; 2004 Feb; 50(2):565-9. PubMed ID: 14872500
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies directed to novel components of the PM/Scl complex, the human exosome.
Brouwer R; Vree Egberts WT; Hengstman GJ; Raijmakers R; van Engelen BG; Seelig HP; Renz M; Mierau R; Genth E; Pruijn GJ; van Venrooij WJ
Arthritis Res; 2002; 4(2):134-8. PubMed ID: 11879549
[TBL] [Abstract][Full Text] [Related]
8. Identification of an alpha-helical epitope region on the PM/Scl-100 autoantigen with structural homology to a region on the heterochromatin p25beta autoantigen using immobilized overlapping synthetic peptides.
Blüthner M; Mahler M; Müller DB; Dünzl H; Bautz FA
J Mol Med (Berl); 2000; 78(1):47-54. PubMed ID: 10759029
[TBL] [Abstract][Full Text] [Related]
9. PM1-Alpha ELISA: the assay of choice for the detection of anti-PM/Scl autoantibodies?
Mahler M; Fritzler MJ
Autoimmun Rev; 2009 Mar; 8(5):373-8. PubMed ID: 19103309
[TBL] [Abstract][Full Text] [Related]
10. Anti-PM/Scl antibodies are found in Japanese patients with various systemic autoimmune conditions besides myositis and scleroderma.
Muro Y; Hosono Y; Sugiura K; Ogawa Y; Mimori T; Akiyama M
Arthritis Res Ther; 2015 Mar; 17(1):57. PubMed ID: 25885224
[TBL] [Abstract][Full Text] [Related]
11. Clinical and serologic correlates of anti-PM/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients.
D'Aoust J; Hudson M; Tatibouet S; Wick J; ; Mahler M; Baron M; Fritzler MJ
Arthritis Rheumatol; 2014 Jun; 66(6):1608-15. PubMed ID: 24577935
[TBL] [Abstract][Full Text] [Related]
12. Anti-PM/Scl-100 and anti-RNA-polymerase III antibodies in scleroderma.
Maes L; Blockmans D; Verschueren P; Westhovens R; De Beéck KO; Vermeersch P; Van den Bergh K; Burlingame RW; Mahler M; Bossuyt X
Clin Chim Acta; 2010 Jul; 411(13-14):965-71. PubMed ID: 20346932
[TBL] [Abstract][Full Text] [Related]
13. The human exosome: an autoantigenic complex of exoribonucleases in myositis and scleroderma.
Brouwer R; Pruijn GJ; van Venrooij WJ
Arthritis Res; 2001; 3(2):102-6. PubMed ID: 11178117
[TBL] [Abstract][Full Text] [Related]
14. Anti-PM-Scl antibody in patients with systemic sclerosis.
Koschik RW; Fertig N; Lucas MR; Domsic RT; Medsger TA
Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S12-6. PubMed ID: 22261302
[TBL] [Abstract][Full Text] [Related]
15. Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients.
Hanke K; Brückner CS; Dähnrich C; Huscher D; Komorowski L; Meyer W; Janssen A; Backhaus M; Becker M; Kill A; Egerer K; Burmester GR; Hiepe F; Schlumberger W; Riemekasten G
Arthritis Res Ther; 2009; 11(1):R22. PubMed ID: 19220911
[TBL] [Abstract][Full Text] [Related]
16. C1D is a major autoantibody target in patients with the polymyositis-scleroderma overlap syndrome.
Schilders G; Egberts WV; Raijmakers R; Pruijn GJ
Arthritis Rheum; 2007 Jul; 56(7):2449-54. PubMed ID: 17599775
[TBL] [Abstract][Full Text] [Related]
17. Identification of protein components reactive with anti-PM/Scl autoantibodies.
Gelpi C; Algueró A; Angeles Martinez M; Vidal S; Juarez C; Rodriguez-Sanchez JL
Clin Exp Immunol; 1990 Jul; 81(1):59-64. PubMed ID: 2199097
[TBL] [Abstract][Full Text] [Related]
18. Cloning and characterization of the cDNA coding for a polymyositis-scleroderma overlap syndrome-related nucleolar 100-kD protein.
Blüthner M; Bautz FA
J Exp Med; 1992 Oct; 176(4):973-80. PubMed ID: 1383382
[TBL] [Abstract][Full Text] [Related]
19. Anti-Ku antibodies in connective tissue diseases: clinical and serological evaluation of 14 patients.
Franceschini F; Cavazzana I; Generali D; Quinzanini M; Viardi L; Ghirardello A; Doria A; Cattaneo R
J Rheumatol; 2002 Jul; 29(7):1393-7. PubMed ID: 12136894
[TBL] [Abstract][Full Text] [Related]
20. [Idiopathic inflammatory myopathies with anti-PM-Scl antibodies: case series and literature review].
Marie I; Lahaxe L; Tiev K; Duval-Modeste AB; Vittecoq O; Levesque H; Jouen F
Rev Med Interne; 2010 Aug; 31(8):540-4. PubMed ID: 20510485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
